“B-ZERO” - Accelerating progress towards HBV elimination in Africa by using treatment to deliver aviraemia

Ente: WT

Scadenza: 2031-07-01

Importo max: 4.103.580 €

Paese: EU

Descrizione

Hepatitis B virus (HBV) causes over 250 million chronic infections worldwide, with a disproportionate burden in Africa. Oral nucleos(t)ide analogue (NA) treatment is prescribed to suppress viraemia and curb transmission, but is not curative. New WHO guidelines increase treatment eligibility from 50%

Registrati gratis su Bandolo per trovare bandi compatibili con la tua azienda.